Related Experiment Video

Updated: Aug 8, 2026

Preparation of Quality Inositol Pyrophosphates
10:34

Preparation of Quality Inositol Pyrophosphates

Published on: September 3, 2011

[Effect of mineral phosphorus on mycoheptin biosynthesis]

T A Koroleva, N A Kuznetsova, A I Larkin

    Antibiotiki
    |January 1, 1977
    PubMed

    Insights

    This study found that specific mineral phosphorus concentrations in synthetic media are crucial for optimal mycoheptin (antifungal antibiotic) biosynthesis. Phosphorus levels influence both mycelial productivity and organism growth, offering a control factor for antibiotic production.

    Area of Science:

    • Microbiology
    • Biochemistry
    • Pharmacology

    Background:

    • Mycoheptin is an antifungal antibiotic with potential therapeutic applications.
    • Optimizing the biosynthesis of antibiotics is crucial for efficient production.
    • Mineral phosphorus is an essential nutrient for microbial growth and metabolism.

    Purpose of the Study:

    • To investigate the effect of varying mineral phosphorus concentrations on mycoheptin biosynthesis.
    • To determine the optimal phosphorus levels for mycelial productivity and organism growth.
    • To explore the role of phosphorus as a limiting factor in controlling antibiotic production.

    Main Methods:

    • Cultivation of the antibiotic-producing organism in a synthetic medium with controlled mineral phosphorus concentrations (22.8 to 684 gamma/ml).
    • Measurement of mycelial productivity and organism growth at different phosphorus levels.
    • Assessment of mycoheptin biosynthesis in response to phosphorus concentration.

    Main Results:

    • Maximum mycelial productivity was observed at phosphorus concentrations of 22.8--45.6 gamma/ml.
    • An optimal phosphorus concentration of 91.2 gamma/ml was identified for the growth of the antibiotic-producing organism.
    • Optimal phosphorus concentrations for growth and antibiotic synthesis phases were found to be distinct, indicating phosphorus's role as a limiting factor.
    • Higher phosphorus concentrations (6 times optimal) did not inhibit biomass accumulation or significantly affect colony morphology.

    Conclusions:

    • Mineral phosphorus concentration is a critical factor that can be manipulated to control mycoheptin biosynthesis.
    • Distinct optimal phosphorus levels exist for microbial growth and antibiotic production, allowing for targeted process optimization.
    • Understanding these distinct requirements enables the use of phosphorus as a regulatory element in antibiotic fermentation.

    More Related Videos

    Quantification of Fungal Colonization, Sporogenesis, and Production of Mycotoxins Using Kernel Bioassays10:01

    Quantification of Fungal Colonization, Sporogenesis, and Production of Mycotoxins Using Kernel Bioassays

    Published on: April 23, 2012

    Strategies to Enhance Cultivation of Anaerobic Bacteria from Gastrointestinal Tract of Chicken04:36

    Strategies to Enhance Cultivation of Anaerobic Bacteria from Gastrointestinal Tract of Chicken

    Published on: May 10, 2024

    Related Concept Videos

    Phosphoinositides and PIPs01:42

    Phosphoinositides and PIPs

    Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
    Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
    Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

    Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

    In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
    Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

    Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

    Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
    Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

    Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

    PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
    Fungal Phylum Microsporidia01:28

    Fungal Phylum Microsporidia

    Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
    Antifungal Agents01:15

    Antifungal Agents

    Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...